Aklief

Active Ingredient(s): Trifarotene
FDA Approved: * October 4, 2019
Pharm Company: * GALDERMA RESEARCH AND DEV INC
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Recent Aklief Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Trifarotene
  • Cream: 0.005%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Aklief: (1 result)

Sorted by National Drug Code
  • 0299-5935 Aklief 50 ug/g Topical Cream by Galderma Laboratories, L.p.

Other drugs which contain Trifarotene or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 8 April 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA